Phase 2 Liver Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People aged between 18 and 85 years old
- People who have an advanced solid tumor (a type of cancer) that has come back or has not responded to previous treatment
- People whose doctors estimate they are likely to live for more than three months
Who may not be able to join:
- People who have a benign tumor (a growth that is not cancerous)
- People whose doctors estimate they are likely to live for less than three months
- People who have serious other medical conditions (confirm with trial site for specific details)
- People who fall into other unspecified categories that may affect eligibility (confirm with trial site for specific details)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Zhenfeng Zhang, MD, PhD, Second Affiliated Hospital of Guangzhou Medical University
Phone: +862039195966
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Assessing Incidence of Treatment-Emergent Adverse Events during the treatment and various responses to the treatment.
Can't join this trial?
Data last synced from ClinicalTrials.gov: 7 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.